Compile Data Set for Download or QSAR
maximum 50k data
Found 14 Enz. Inhib. hit(s) with all data for entry = 9687
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481754(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-(4- phenylpip...)
Affinity DataIC50:  400nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481757(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-[4-(1- methyl...)
Affinity DataIC50:  800nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481749(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-[4-(2- pyridy...)
Affinity DataIC50:  900nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481758(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-[4-(2- methyl...)
Affinity DataIC50:  900nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481745(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-(4- pyrimidin...)
Affinity DataIC50:  1.00E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481747(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-[4-(3- pyridy...)
Affinity DataIC50:  1.00E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481756(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-[4-(1H- pyraz...)
Affinity DataIC50:  1.00E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481750(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-(4- pyrimidin...)
Affinity DataIC50:  1.10E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481755(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-[4-(1H- pyraz...)
Affinity DataIC50:  1.10E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481753(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-(4- pyrazin-2...)
Affinity DataIC50:  1.20E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481744(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-(4- pyrimidin...)
Affinity DataIC50:  1.40E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481752(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-(4- pyridazin...)
Affinity DataIC50:  1.40E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481751(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-(4- pyridazin...)
Affinity DataIC50:  1.50E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biopharma

US Patent
LigandPNGBDBM481746(N-[1-(1H-indol-3- ylmethyl)pentyl]-2-[4-(4- pyridy...)
Affinity DataIC50:  2.70E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent